Neuroanesthesia & neurocritical care

Time-weighted lactate and glucose–lactate ratio outperform static values in ICU mortality prediction after traumatic brain injury: a retrospective cohort study

J Intensive CarePublished Retrospective cohort study

Authors' conclusion

In critically ill non-diabetic patients with TBI, longitudinal time-weighted average lactate significantly outperformed admission values and glucose metrics for predicting ICU mortality in a severity-balanced cohort; the glucose-lactate ratio was associated but did not surpass lactate.

Study context

Population
Non-diabetic adults with traumatic brain injury (TBI) admitted to a German university ICU (2013–2023)matched from 479
Participants
229 adults
Exposure
Survivors vs Non-survivors
  • Survivorsn = 150reference
  • Non-survivorsn = 79
Outcome
ICU mortality
Methodological detailssingle-centre, 1:2 severity-balanced, outcome-stratified propensity-score matched
  • Single-centre
  • 1:2 severity-balanced, outcome-stratified propensity-score matched

Main finding

As reported in the abstract

ICU mortality prediction

Time-weighted average lactate: best independent predictor, OR

14.70

95% CI 5.41–39.98p < 0.001

Time-weighted average lactate AUC

0.73

Time-weighted average glucose-lactate ratio: independent predictor, OR

0.75

95% CI 0.66–0.86p < 0.001

Observational data: associations, not effects.

Further findings

Daily lactate, Non-survivors vs Survivors · first ten ICU days

Non-survivors persistently higher glucose, lactate and lower ratios; lactate significantly elevated on all first ten ICU days
all p < 0.05

Original publication

Time-weighted lactate and glucose–lactate ratio outperform static values in ICU mortality prediction after traumatic brain injury: a retrospective cohort study. J Intensive Care. Published 7 February 2026. doi:10.1186/s40560-026-00864-9

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.